Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-13-029947)

Filing Details

Accession Number:: 0001144204-13-029947
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-16 16:34:23
Reporting Period:: 2013-05-14

Filing Date:: 2013-05-16
Accepted Time:: 2013-05-16 16:34:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235007	Endocyte Inc	ECYT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509415	P Christopher Leamon	3000 Kentave, Suite A1-100 West Lafayette IN 47906	Vice President Of Research	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-05-14	5,000	$14.70	10,073	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the sale of 5,000 shares in multiple transactions, ranging in price from $14.63 to $14.82 per share, resulting in a weighted average sale price per share of $14.70. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.